CDC’s Investments to Combat Antibiotic Resistance Threats: Minnesota: Fiscal Year 2020

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.) ; Centers for Disease Control and Prevention (U.S.)
• Description:
  Funding for AR Activities Fiscal Year 2020: $7,146,901
  
  2 local CDC fellows
  
  Regional Lab for the AR Lab Network (Central)
  
  One of 10 sites for the Emerging Infections Program
  
  Publication date from document properties.
  
  Minnesota-CDC-AR-Investments.pdf
  
  
• Series:
  Antibiotic Resistance (AR) Solutions in Action   ; Antibiotic Resistance (AR) Solutions in Action  
• Document Type:
  Text
• Genre:
  Pamphlet (or booklet) ; Pamphlet (or booklet)
• Place as Subject:
  Minnesota
• Federal Fiscal Year:
  2020
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:ffc9c919dc850797713761a425ed22776868683b5f90d31f9939818cd0cf9372715d8a20313938db618e27bf3a8a0891b9f9d43766dd7c69e17c3ed5c633d70a
• Download URL:
  https://stacks.cdc.gov/view/cdc/102358/cdc_102358_DS1.pdf
• File Type:
  [PDF - 527.50 KB ]